Peter Y. Chuang

4.3k total citations
54 papers, 3.3k citations indexed

About

Peter Y. Chuang is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Peter Y. Chuang has authored 54 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Nephrology, 17 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Peter Y. Chuang's work include Renal Diseases and Glomerulopathies (28 papers), Chronic Kidney Disease and Diabetes (15 papers) and Systemic Lupus Erythematosus Research (7 papers). Peter Y. Chuang is often cited by papers focused on Renal Diseases and Glomerulopathies (28 papers), Chronic Kidney Disease and Diabetes (15 papers) and Systemic Lupus Erythematosus Research (7 papers). Peter Y. Chuang collaborates with scholars based in United States, China and United Kingdom. Peter Y. Chuang's co-authors include John Cijiang He, Kyung Lee, Yifei Zhong, Jia Fu, Belinda Jim, Zhihong Liu, Madhav C. Menon, Avi Ma’ayan, Yan Dai and Ying Fan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Peter Y. Chuang

54 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Y. Chuang 1.5k 1.4k 383 340 296 54 3.3k
Motohide Isono 1.5k 1.0× 1.6k 1.1× 255 0.7× 295 0.9× 181 0.6× 43 3.6k
Kerri Thai 654 0.4× 1.4k 1.0× 220 0.6× 178 0.5× 133 0.4× 63 3.0k
Ae Seo Deok Park 1.1k 0.7× 1.1k 0.7× 218 0.6× 328 1.0× 260 0.9× 8 2.4k
Evelyn Tolbert 968 0.6× 1.1k 0.8× 214 0.6× 186 0.5× 150 0.5× 40 2.7k
Guie Dong 1.0k 0.7× 1.5k 1.1× 177 0.5× 533 1.6× 144 0.5× 28 3.1k
Junhui Zhen 575 0.4× 807 0.6× 288 0.8× 290 0.9× 125 0.4× 54 2.0k
Günter Wolf 1.5k 1.0× 1.6k 1.1× 418 1.1× 276 0.8× 274 0.9× 70 4.5k
Guixia Ding 633 0.4× 937 0.6× 157 0.4× 178 0.5× 128 0.4× 68 2.0k
Eliyahu V. Khankin 519 0.3× 926 0.6× 432 1.1× 423 1.2× 72 0.2× 41 2.7k
Dongshan Zhang 887 0.6× 1.3k 0.9× 385 1.0× 407 1.2× 106 0.4× 77 2.9k

Countries citing papers authored by Peter Y. Chuang

Since Specialization
Citations

This map shows the geographic impact of Peter Y. Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Y. Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Y. Chuang more than expected).

Fields of papers citing papers by Peter Y. Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Y. Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Y. Chuang. The network helps show where Peter Y. Chuang may publish in the future.

Co-authorship network of co-authors of Peter Y. Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Y. Chuang. A scholar is included among the top collaborators of Peter Y. Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Y. Chuang. Peter Y. Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Yuanmeng, Peter Y. Chuang, Ying Fan, et al.. (2021). Publisher Correction: A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nature Medicine. 27(8). 1483–1483. 1 indexed citations
2.
Zhong, Fang, Haibing Chen, Yifan Xie, et al.. (2018). Protein S Protects against Podocyte Injury in Diabetic Nephropathy. Journal of the American Society of Nephrology. 29(5). 1397–1410. 33 indexed citations
3.
Hong, Quan, Lu Zhang, Bhaskar C. Das, et al.. (2018). Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury. Kidney International. 93(6). 1330–1343. 174 indexed citations
4.
Fu, Jia, Zichen Wang, Kyung Lee, et al.. (2017). Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis. Kidney International. 93(2). 416–429. 31 indexed citations
5.
Dai, Yan, Anqun Chen, Ruijie Liu, et al.. (2017). Retinoic acid improves nephrotoxic serum–induced glomerulonephritis through activation of podocyte retinoic acid receptor α. Kidney International. 92(6). 1444–1457. 29 indexed citations
6.
Mallipattu, Sandeep K., Vivette D. D’Agati, Goutham Narla, et al.. (2015). Krüppel-like factor 6 regulates mitochondrial function in the kidney. Journal of Clinical Investigation. 125(3). 1347–1361. 65 indexed citations
7.
Fu, Jia, Chengguo Wei, Kyung Lee, et al.. (2015). Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes. Journal of the American Society of Nephrology. 27(4). 1006–1014. 37 indexed citations
8.
Zhong, Fang, Chengguo Wei, Weijia Zhang, et al.. (2014). Reduced Krüppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy. Kidney International. 87(2). 382–395. 52 indexed citations
9.
Tao, Hua, Zhaohui Ni, Yucheng Yan, et al.. (2014). cAMP Signaling Prevents Podocyte Apoptosis via Activation of Protein Kinase A and Mitochondrial Fusion. PLoS ONE. 9(3). e92003–e92003. 32 indexed citations
10.
Dai, Yan, Leyi Gu, Weijie Yuan, et al.. (2013). Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum–induced glomerulonephritis. Kidney International. 84(5). 950–961. 44 indexed citations
11.
Mallipattu, Sandeep K., Ruijie Liu, Yifei Zhong, et al.. (2013). Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney International. 83(4). 626–634. 52 indexed citations
12.
Jiang, Song, Peter Y. Chuang, Zhihong Liu, & John Cijiang He. (2013). The primary glomerulonephritides: a systems biology approach. Nature Reviews Nephrology. 9(9). 500–512. 20 indexed citations
13.
Gu, Leyi, Yan Dai, Jin Xu, et al.. (2013). Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS. 27(7). 1091–1098. 36 indexed citations
14.
Zhang, Guangtao, Ruijie Liu, Yifei Zhong, et al.. (2012). Down-regulation of NF-κB Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition. Journal of Biological Chemistry. 287(34). 28840–28851. 163 indexed citations
15.
Zhong, Yifei, Yingwei Wu, Ruijie Liu, et al.. (2012). Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure. Kidney International. 81(9). 856–864. 22 indexed citations
16.
Jim, Belinda, Mythili Ghanta, Andi Qipo, et al.. (2012). Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study. PLoS ONE. 7(5). e36041–e36041. 146 indexed citations
17.
Chuang, Peter Y., Madhav C. Menon, & John Cijiang He. (2012). Molecular targets for treatment of kidney fibrosis. Journal of Molecular Medicine. 91(5). 549–559. 70 indexed citations
18.
Zhong, Yifei, Yingwei Wu, Ruijie Liu, et al.. (2011). Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease. PLoS ONE. 6(11). e27945–e27945. 38 indexed citations
19.
Lu, Ting-Chi, Zhaohui Wang, Xiaobei Feng, et al.. (2009). Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy. Kidney International. 76(1). 63–71. 98 indexed citations
20.
Chuang, Peter Y., Qianqian Yu, Wei Fang, Jaime Uribarri, & John Cijiang He. (2007). Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney International. 72(8). 965–976. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026